Repair of neonatal brain injury: bringing stem cell-based therapy into clinical practice

Area of Science:

• Neonatal neurology
• Regenerative medicine
• Neuroprotection

Background:

• Hypoxic-ischaemic brain injury is a major cause of death and disability in newborns.
• Current treatments primarily manage symptoms, with hypothermia being the only proven neuroprotective strategy for perinatal hypoxic-ischaemic encephalopathy.
• Stem cell-based therapies offer a potential avenue for brain regeneration in neonates.

Purpose of the Study:

• To review the current status of stem cell-based therapies for neonatal brain injury.
• To identify potential challenges and opportunities for clinical application.
• To highlight mesenchymal stromal cells as promising candidates for neuroregeneration.

Main Methods:

• Review of existing literature on stem cell therapy for neonatal brain injury.
• Analysis of experimental and preclinical data.
• Discussion of clinical translation challenges and prospects.

Main Results:

• Mesenchymal stromal cells exhibit promising neuroregenerative properties and a favorable safety profile for neonatal use.
• Experimental results suggest significant potential for stem cell therapies in treating neonatal brain injury.
• Clinical translation efforts are increasing, indicating a move towards therapeutic application.

Conclusions:

• Stem cell-based therapies, particularly using mesenchymal stromal cells, represent a promising future direction for treating neonatal brain injury.
• Overcoming hurdles in clinical translation is crucial for realizing the potential of these therapies.
• Further research and development are needed to bring these regenerative strategies to the bedside.